Article
Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathway
2023-08-31
Abstract excerpt
<title>Abstract</title> <p><bold>Objective: </bold>Intestinal fibrosis is a common complication of inflammatory bowel disease and is characterized by tissue stiffening and luminal narrowing. Dihydromyricetin (DHM) can alleviate liver fibrosis and renal interstitial fibrosis by inducing autophagy. However, whether DHM can alleviate intestinal fibrosis remains unclear. This study aimed to evaluate the role and mech...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 52516b73-8251-5954-9b03-302ad7a48b03
- DOI
- 10.21203/rs.3.rs-3305044/v1
